Skip to search boxSkip to navigationSkip to main content

Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus

  • Balaji Manicassamy
    ,
  • ,
  • Alan Belicha-Villanueva
    ,
  • Giuseppe Pisanelli
    ,
  • Bali Pulendran
    ,
  • Adolfo García-Sastre(corresponding author)
*Corresponding author for this work
  • Icahn School of Medicine at Mount Sinai
    ,
  • Emory University
    ,
  • University of Naples Federico II
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Influenza A virus is being extensively studied because of its major impact on human and animal health. However, the dynamics of influenza virus infection and the cell types infected in vivo are poorly understood. These characteristics are challenging to determine, partly because there is no efficient replication-competent virus expressing an easily traceable reporter gene. Here, we report the generation of a recombinant influenza virus carrying a GFP reporter gene in the NS segment (NS1-GFP virus). Although attenuated when compared with wild-type virus, the NS1-GFP virus replicates efficiently in murine lungs and shows pathogenicity in mice. Using whole-organ imaging and flow cytometry, we have tracked the dynamics of influenza virus infection progression in mice. Imaging of murine lungs shows that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs. In addition to epithelial cells, we found GFP-positive antigen-presenting cells, such as CD11b+CD11c -, CD11b-CD11c+, and CD11b +CD11c+, as early as 24 h after intranasal infection. In addition, a significant proportion of NK and B cells were GFP positive, suggesting active infection of these cells. We next tested the effects of the influenza virus inhibitors oseltamivir and amantadine on the kinetics of in vivo infection progression. Treatment with oseltamivir dramatically reduced influenza infection in all cell types, whereas, surprisingly, amantadine treatment more efficiently blocked infection in B and NK cells. Our results demonstrate high levels of immune cells harboring influenza virus antigen during viral infection and cell-type - specific effects upon treatment with antiviral agents, opening additional avenues of research in the influenza virus field.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 11531-11536 (6 pages)

Journal (Volume, Issue Number)

Proceedings of the National Academy of Sciences of the United States of America (Volume 107, Issue 25)

Publication milestones

  • Published - 06/22/2010

Publication status

Published - 06/22/2010

ISSN

0027-8424

Publication IDs

  • Scopus: 77954889069
  • PubMed: 20534532

Publication metrics

Metrics

Scopus
citations
SciVal
FWCI
2.95
SciVal
Author count
6
SciVal
citations
287
SciVal
Paper percentile
99
SciVal
Top percentile
1
Fractional count
1
Fractional count
0.17
Fractional count
5
Fractional count
0.83
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
380
Captures
450

Funding Details

FunderFunding number
NIAID
P01AI058113